Rethinking Opioids: Key Considerations for Balancing Pain Management and Patient Risk
Martin Cheatle, PhD
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
The Complexities Behind Lupus: Understanding its Multifactorial Mechanisms
Michelle Kahlenberg, MD, PhD
Evolving Strategies in Lupus Care: Recent Findings and Ongoing Challenges
Tailoring Approaches to Pediatric Rheumatic Disease: Best Practices for Long-Term Management
John Bridges, MD, MS
Unmasking IgG4-Related Disease: Best Practices for Accurate Diagnosis and Optimal Care
Matthew Baker, MD, MS
Breaking Ground in Bone Health: Key Takeaways from ISO 2025
Marshall Miller
Ami R. Patel
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Atul A. Deodhar, MD, MRCP
Rethinking Pain: Care Strategies for Patients with Rheumatic Diseases
Philip J. Mease, MD, MACR
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Robin Dore, MD
The Aryl Hydrocarbon Receptor and Lupus: Diagnostic and Therapeutic Advancements
Gates B. Colbert, MD
Deepak Rao, MD, PhD
Coronary Risk in Rheumatoid Arthritis: Rural vs. Urban Hospitalization Disparities
Jasvinder Singh, MD
Using Ultrasound to Differentiate Rheumatoid Arthritis and Psoriatic Arthritis
Erin Chew, MD
Can AI Match Expert Rheumatologists? Insights from ARTHUR+DIANA’s Evaluation Study
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
John H. Stone, MD, MPH
Emanuel Della Torre, MD, PhD
Yoh Zen, MD, PhD, FRCPath
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Emma Culver, BSc, MD, PhD, FRCP
Louisa Catherine Firmin, MBChB, MRCS, FRCR
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.